Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I B Runnebaum

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 3, 1998
Pregnancy outcome after repeated blunt abdominal traumaI B Runnebaum, G Holcberg, M Katz
Journal of Cancer Research and Clinical Oncology|March 1, 2018
Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatmentA R Mothes, M Runnebaum, I B Runnebaum
Andrologia|March 1, 1995
ConA-binding proteins of the sperm surface are conserved through evolution and in sperm maturationI B Runnebaum, W B Schill, E Töpfer-Petersen
British Journal of Cancer|October 25, 2000
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian massF D Vogl, M Frey, R Kreienberg, et al.
Journal of Perinatal Medicine|January 1, 1989
Inhibitors and activators of fibrinolysis during and after childbirth in maternal and cord bloodI B Runnebaum, S M Maurer, L Daly, et al.
Cancer Gene Therapy|November 1, 2001
Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cellsG Saretzki, A Ludwig, T von Zglinicki, et al.
Human Molecular Genetics|September 1, 1993
p53 gain-of-function mutation in codon 175 is a rare event in human breast cancerI B Runnebaum, D G Kieback, X W Tong, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 1, 2006
[Choriocarcinoma]A Petrovitch, H Diebolder, C Kurrat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Mutations in p53 as potential molecular markers for human breast cancerI B Runnebaum, M Nagarajan, M Bowman, et al.
Archives of Gynecology and Obstetrics|August 27, 2015
Risk index for pelvic organ prolapse based on established individual risk factorsA R Mothes, M P Radosa, A Altendorf-Hofmann, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 3, 1998
Pregnancy outcome after repeated blunt abdominal traumaI B Runnebaum, G Holcberg, M Katz
Journal of Cancer Research and Clinical Oncology|March 1, 2018
Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatmentA R Mothes, M Runnebaum, I B Runnebaum
Andrologia|March 1, 1995
ConA-binding proteins of the sperm surface are conserved through evolution and in sperm maturationI B Runnebaum, W B Schill, E Töpfer-Petersen
British Journal of Cancer|October 25, 2000
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian massF D Vogl, M Frey, R Kreienberg, et al.
Journal of Perinatal Medicine|January 1, 1989
Inhibitors and activators of fibrinolysis during and after childbirth in maternal and cord bloodI B Runnebaum, S M Maurer, L Daly, et al.
Cancer Gene Therapy|November 1, 2001
Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cellsG Saretzki, A Ludwig, T von Zglinicki, et al.
Human Molecular Genetics|September 1, 1993
p53 gain-of-function mutation in codon 175 is a rare event in human breast cancerI B Runnebaum, D G Kieback, X W Tong, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 1, 2006
[Choriocarcinoma]A Petrovitch, H Diebolder, C Kurrat, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Mutations in p53 as potential molecular markers for human breast cancerI B Runnebaum, M Nagarajan, M Bowman, et al.
Archives of Gynecology and Obstetrics|August 27, 2015
Risk index for pelvic organ prolapse based on established individual risk factorsA R Mothes, M P Radosa, A Altendorf-Hofmann, et al.
Pageof 8